Despite being extremely old concepts, plasmonics and surface plasmon resonance-based biosensors have been increasingly popular in the recent two decades due to the growing interest in nanooptics and are now of significant significance in regards to applications associated with human health. Plasmonics used in health surveillance systems have a high sensitivity and meets the standards for sensitivity, selectivity, and detection limit. In addition, integration into microsystems and point-of-care devices has enabled significant levels of sensitivity and limit of detection to be achieved. All of this has encouraged the expansion of the fields of study and market niches devoted to the creation of quick and incredibly sensitive label-free detection. The trend is reflected in the development of wearable plasmonic sensors as well as point-of-care applications for widespread applications, demonstrating the potential impact of the new generation of plasmonic biosensors on human well-being through the concepts of personalized medicine and global health.In this context, the aim here is to discuss the potential, limitations, and opportunities for improvement that have arisen as a result of the integration of plasmonics into microsystems and lab-on-chip over the past five years. Recent applications of plasmonic biosensors in microsystems and their sensor performance are analyzed. The final discussion focuses on the integration of microfluidics and lab-on-a-chip with quantum plasmonics technology as a promising solution for chemical and biological sensing applications. Aiming to overcome the limits given by quantum fluctuations and noise, research in the field of quantum plasmonic sensing for biological applications has flourished over the past decade. The significant advances in nanophotonics, plasmonics and microsystems used to create increasingly effective biosensors would continue to benefit this field if harnessed properly.